- Exchange: NASDAQ CM
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Prana Biotechnology Ltd
+ Add to WatchlistPRAN:US
2.3900 USD 0.1001 4.37%As of 20:10:00 ET on 05/24/2013.
Snapshot for Prana Biotechnology Ltd (PRAN)
| Open: | 2.2900 | Day's Range: | 2.2300 - 2.3900 | Volume: | 85,145 |
|---|---|---|---|---|---|
| Previous Close: | 2.3900 | 52wk Range: | 1.4500 - 3.0600 | 1-Yr Rtn: | +53.21% |
Key Statistics for PRAN
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(06/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (ttm) | - |
| Est. EPS (06/2013) | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 91.20 |
| Shares Outstanding (M) | 38.16 |
| 30 Day Average Volume | 83,161 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 09/02/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for PRAN
Company Profile & Key Executives for PRAN
Prana Biotechnology Limited is an Australian biotechnology company which researches and develops therapeutic drugs used for treatment of Alzheimer's Disease and other age-related degenerative disorders such as Parkinson's Disease and cataracts.
| Geoffrey P KemplerChairman/CEO/Founder | Richard RevelinsCFO/Secretary |
| Diane AngusChief Operating Officer | Rudolph E Tanzi "Rudy"Chief Scientific Advisor |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
PRAN News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page